Spontaneous fractures during 13‐cis retinoic acid therapy for neuroblastoma

solid malignancy. 1 Current

[1]  M. Kang,et al.  Physeal Abnormalities in Children With High-risk Neuroblastoma Intensively Treated With/Without 13-Cis-Retinoic Acid , 2021, Journal of pediatric orthopedics.

[2]  H. Mulla,et al.  Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial , 2021, Cancers.

[3]  B. Miziołek,et al.  The safety of isotretinoin treatment in patients with bone fractures , 2019, Postepy dermatologii i alergologii.

[4]  Valeria R Smith,et al.  High-Risk Neuroblastoma Treatment Review , 2018, Children.

[5]  Eva Steliarova-Foucher,et al.  International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.

[6]  Vikas Prasad,et al.  2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors , 2017, Klinische Pädiatrie.

[7]  J. M. Mata-Granados,et al.  Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women , 2013, Archives of Osteoporosis.

[8]  A. Boddy,et al.  Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma , 2012, Clinical Cancer Research.

[9]  A. Boddy,et al.  Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group , 2007, British Journal of Cancer.

[10]  S. Ferguson,et al.  Oral treatment with retinoic acid decreases bone mass in rats. , 2006, Comparative medicine.

[11]  K. Michaëlsson,et al.  Serum retinol levels and the risk of fracture. , 2003, The New England journal of medicine.

[12]  W. Willett,et al.  Vitamin A intake and hip fractures among postmenopausal women. , 2002, JAMA.

[13]  K. Matthay,et al.  Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  N. Sidell,et al.  Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. , 1982, Journal of the National Cancer Institute.

[15]  L. Snetselaar,et al.  Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study. , 2009, The American journal of clinical nutrition.

[16]  K. Matthay,et al.  Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. , 1999, The New England journal of medicine.

[17]  J. Villablanca,et al.  Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation , 1996, Cancer Chemotherapy and Pharmacology.

[18]  S. Shurin,et al.  Response of neuroblastoma to retinoic acid in vitro and in vivo. , 1991, Progress in clinical and biological research.